Tag: Cancer
-
Nation & World
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds…
-
Nation & World
Broad scientists to sequence multiple myeloma samples
The Multiple Myeloma Research Foundation (MMRF) announced today a collaboration with the Broad Institute of Harvard and MIT to systematically uncover the molecular changes underlying multiple myeloma by whole-genome sequencing…
-
Nation & World
Cancer chemotherapy: An unfolding story
To launch his lecture on cancer chemotherapy, Luke Whitesell ’79, RI ’06 displayed an image of an origami crab: a double visual metaphor. The crab is the traditional symbol of…
-
Nation & World
Despite economy, Daffodil Days still comes up roses
With good news comes the bad news. This year’s Daffodil Days, held on March 16, raised $51,726 in funds for the American Cancer Society — the first time in its 22-year history that this year’s total did not surpass the previous year’s total ($53,329). However, with the economic downturn taken into consideration, “I still think…
-
Nation & World
A more direct delivery of cancer drugs to tumors
An interdisciplinary team of researchers at Brigham and Women’s Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology (HST) has demonstrated a better way to deliver cancer drugs…
-
Nation & World
HMS professor devises single test for cancers
Imagine visiting a doctor’s office five years from now and, as a routine part of your annual physical, getting an accurate test that can tell whether you have cancer long…
-
Nation & World
Breast cancer danger rising in developing countries
Women in developing nations, once thought to have a small chance of contracting breast cancer, are increasingly getting the disease as lifestyles incorporate risk factors common in industrialized nations, panelists at the Harvard School of Public Health (HSPH) said Tuesday (April 14).
-
Nation & World
Breast cancer danger rising in developing world
Women in developing nations, once thought to have a small chance of contracting breast cancer, are increasingly getting the disease as lifestyles incorporate risk factors common in industrialized nations, panelists at the Harvard School of Public Health (HSPH) said Tuesday (April 14).
-
Nation & World
For cancer cells, genetics alone is poor indicator for drug response
In certain respects, cells are less like machines and more like people. True, they have lots of components, but they also have lots of personality. For example, when specific groups…
-
Nation & World
Angiogenesis inhibitor improves brain tumor survival by reducing swelling
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema – the swelling of brain tissue…
-
Nation & World
Newly identified genetic variants found to increase breast cancer risk
A large-scale effort to identify genetic markers of breast cancer has uncovered two common genetic variants that increase risk of the disease in women of European ancestry. The paper, published…
-
Nation & World
Link found between religious belief, intensive medical care at end of life
In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found that those who draw on religion to cope with their illness are more likely to…
-
Nation & World
Blood types indicate greater risk for cancer
Offering a novel clue about the basic biology of pancreatic cancer, researchers at Dana-Farber Cancer Institute have confirmed a decades-old discovery of a link between blood type and the risk of developing the disease.
-
Nation & World
Blood type study sheds light on biology of pancreatic cancer
Offering a novel clue about the basic biology of pancreatic cancer, researchers at Dana-Farber Cancer Institute have confirmed a decades-old discovery of a link between blood type and the risk…
-
Nation & World
Runyon Foundation names fellows from Harvard
The Damon Runyon Cancer Research Foundation has named six Harvard affiliates among its 13 new fellows. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.
-
Nation & World
Friday marks daffodil deadline
With spring’s anticipated return still weeks away, there’s a beacon of yellow hope. Daffodils are an invigorating component in the American Cancer Society’s (ACS) efforts, and Harvard is again a key participant in Daffodil Days, the ACS’s annual flowery fight to help patients and eradicate cancer.
-
Nation & World
Cancer Society’s daffodils can drive away winter blues
With months until spring’s anticipated return comes a beacon of yellow hope. Daffodils are an invigorating component in the American Cancer Society’s (ACS) efforts, and Harvard is again a key participant in Daffodil Days, the ACS’s annual flowery fight to help patients and eradicate cancer.
-
Nation & World
Blavatnik Family Foundation gives Harvard $10M
The Blavatnik Family Foundation, headed by Len Blavatnik, M.B.A. ’89, has given Harvard University two gifts totaling $10 million in support of its scientific and technological research. Half the gift will go to the Eli and Edythe L. Broad Institute of Harvard and MIT to support cancer vaccine research, and half will go to the…
-
Nation & World
Researchers find new molecule to block ‘Hedgehog’ signaling in cancer, development
Researchers have achieved a feat drug developers had thought difficult, if not impossible, discovering a compound that blocks the functioning of a key developmental protein by binding to an “undruggable”…
-
Nation & World
Hormone therapy for prostate cancer does not appear to increase cardiac deaths
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Harvard Medical…
-
Nation & World
Cutler finds decline in cancer deaths
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
-
Nation & World
Researchers gain ground in treatment options for disfiguring tumor
A team of researchers led by Harvard School of Dental Medicine (HSDM) Dean for Research Bjorn Olsen has discovered a mechanism for the rapid growth seen in infantile hemangioma, the most common childhood tumor.
-
Nation & World
‘Death protein’ may lead to drugs that force cancer cells to self-destruct
Scientists at Dana-Farber Cancer Institute have identified a previously undetected trigger point on a naturally occurring “death protein” that helps the body get rid of unwanted or diseased cells. They say it may be possible to exploit the newly found trigger as a target for designer drugs that would treat cancer by forcing malignant cells…
-
Nation & World
Researchers identify promising gene target for neuroblastoma therapy
Researchers at Dana-Farber Cancer Institute have identified a set of previously unknown mutations in a single gene in 8 percent of neuroblastomas, tumors of the nervous system that occur in young children and account for approximately 15 percent of all childhood cancer deaths.
-
Nation & World
Scientists unlock secret of death protein’s activation
Harvard Medical School researchers at Dana-Farber Cancer Institute have identified a previously undetected trigger point on a naturally occurring “death protein” that helps the body get rid of unwanted or…
-
Nation & World
Major step forward in cell reprogramming
Imagine, if you can, a day within the next decade when a physician-scientist could remove a skin cell from your arm and with a few chemicals turn that fully formed adult cell into a dish of stem cells genetically matched to you.
-
Nation & World
Study shows what smokers need to stay clean
Hospital-sponsored stop-smoking programs for inpatients that include follow-up counseling for longer than one month significantly improve patients’ ability to stay smoke-free. An analysis of clinical trials of programs offered at hospitals around the world finds that efforts featuring long-term support can increase participants’ chances of success by 65 percent.
-
Nation & World
Genetic ‘fingerprint’ shown to predict liver cancer’s return
Scientists have reached a critical milestone in the study of liver cancer that lays the groundwork for predicting the illness’s path, whether toward cure or recurrence. By analyzing the tissue in and around liver tumors, an international research team has identified a kind of genetic “fingerprint” that can help predict whether cancers will return.
-
Nation & World
Study examines association between caffeine, breast cancer risk
Caffeine consumption does not appear to be associated with overall breast cancer risk, according to a report in the Oct. 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, there is a possibility of increased risk for women with benign breast disease or for tumors that are hormone-receptor negative or larger…
-
Nation & World
Caffeine not associated with overall breast cancer risk;
Ken Ishitani of Brigham and Women’s Hospital and Harvard Medical School, and Tokyo Women’s Medical University, Japan, and colleagues report in the Oct. 13 issue of Archives of Internal Medicine…